| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |